Class 3 semaphorins are a family of secreted proteins initially characterized during nervous system development that provide guidance cues to axons, neural crest cells, and endothelial cells (1, 2) . Semaphorins generate chemorepellent signals by inducing growth cone collapse of migrating axons (3), inhibiting endothelial cell migration, or establishing zones of exclusion for cell migration (4 -7) or induce chemoattraction by stimulating migration and survival of axons, neural crest, epithelial or tumoral cells (8 -10) .
Class 3 semaphorins bind to a receptor complex consisting of a binding component, neuropilins 1 or 2, and a signaling component, plexins A1, A2, A3, or D1 (11) (12) (13) . The specificity of the semaphorin signaling depends on the combination of neuropilin/plexin present in dimeric or multimeric receptor complexes in each cell type, e.g., plexin D1 is endothelial cell specific and associates to plexin A1/NP1 to transduce sema 3A signals and to plexin A2/NP2 to transduce semaphorin (sema) 3C signals (5, (12) (13) (14) (15) . Semaphorin signaling engages integrins and small GTPases to regulate the organization of actin cytoskeleton and thereby mediate cell migration and remodeling (12, 16 -18) .
Sema 3A, the prototypical class sema 3 protein, is considered a chemorepellent with proapoptotic functions that induces growth cone collapse and endothelial cell repulsion in vitro and neural pathfinding defects and vascular patterning abnormalities in vivo, resulting in neonatal lethality (6, 19, 20) . Sema 3A signals inhibit integrin activity and induce F-actin depolymerization (6, 20) . Sema 3C provides chemorepulsive guidance to sympathetic neurons and chemoattractive guidance to GABAergic neurons (8, 10, 21) , is a chemoattractant for neural crest cells (22) , and positively regulates branching of the lung epithelium during development (23, 24) . Ablation of the sema 3C gene in mice resulted in severe outflow tract abnormalities, i.e., persistent troncus arteriousus, aortic arch interruption, and mispatterning of intersomitic vessels (25) . Although genetic studies clearly indicate that sema 3C plays a distinct role in endothelial cell guidance and vascular morphogenesis, the mechanisms mediating these effects remain unknown. Similarly, the function of sema 3C in the kidney is unknown.
In the present studies, we tested the hypothesis that sema 3C regulates endothelial cell function using mouse glomerular endothelial cells (MGEC). We determined that sema 3C stimulates glomerular endothelial cell proliferation and survival and enhances their adhesion, directional migration, and tube formation in vitro by stimulating integrin activity and VEGF 120 secretion. Data indicate that sema 3C functions in glomerular endothelial cells are similar to VEGF-A and opposite to sema 3A.
MATERIALS AND METHODS

Cell culture
MGEC, isolated and characterized previously (26) , were grown in MCDB 131 medium (Sigma) supplemented with 15% FBS, 150 g/ml endomitogen, 1 ng/ml epidermal growth factor (EGF), 50 U/ml heparin-Na, 1 g/ml hydrocortisone, and 50 U/ml pen/strep (MCDB 131 complete medium). Cells were maintained at 37°C in 5% CO 2 and were starved 12 h in serum free MCDB medium before each experiment unless otherwise indicated.
Additives and production of recombinant sema 3C
Recombinant human VEGF 165 (R&D Systems) and recombinant sema 3C, 3A, and 3F, generated in our laboratory (27) , were used for MGEC stimulation. Mouse sema 3C cDNA (NM_013657) was cloned into EcoRI/NotI of pHIS.Parallel vector (28) . E. coli BL21 DE3 Codon Plus (Stratagene) were transformed with pHis.Parallel/sema 3C and induced with 1 mM IPTG to produce the recombinant protein. The protein was then extracted from inclusion bodies in denaturing conditions (8 M Urea, 100 mM NaH 2 PO 4 , and 10 mM Tris-HCl) and refolded with a reducing buffer (6 M Urea, 100 mM NaCl, 50 mM Tris-HCl, 10 mM DTT, 1 mM ␤-mercaptoethanol, and 1 mM EDTA) followed by an oxidation buffer (100 mM ClNa, 50 mM Tris-HCl, 10 mM cysteine, 2 mM cysteine, and 1 M l-arginine). Then, the protein was dialyzed against decreasing urea concentration (100 mM NaCl, 50 mM Tris-HCl, 192 mM glycine, and 7 mM urea) and concentrated using Amicon Ultra filters (Millipore).
Reverse-transcription and semiquantitative polymerase chain reaction
Total RNA was isolated from MGEC in control conditions and after 24 h exposure to sema 3C (360 ng/ml) using TRIzol Reagent (Invitrogen Life Technologies, Carlsbad, CA). cDNAs were generated using 2 g total RNA and Superscript II reverse transcriptase (Invitrogen). Semiquantitative polymerase chain reaction (PCR) was performed at 94°C for 3 min once, followed by 25-30 cycles of 94°C for 45 s, 60°C for  30 s, and 72°C for 45 s using the following specific primers:  sema 3C: 5Ј-GCA AAA TGG CTG GCA AAG ATC C-3Ј and  5Ј-CCC ATG AAA TCT ATA TAC ATT CC-3Ј; plexin A1:  5Ј-CCT CGA GAA CAA GAA CCA CCC CAA-3Ј and 5Ј-CCC  TTC ACC GGC ACC TCA GGT GCA TT-3Ј; plexin A2: 5Ј-CCT  CGA GAA CAA GAA CCA CCC CAA-3Ј and 5Ј-AAC ACC TTC  ACT GGG ATC TCT GGA CTG TTC-3Ј; neuropilin 1: 5Ј-GAA  GGC AAC AAC AAC TAT GA-3Ј and 5Ј-ATG CTC CCA GTG  GCA GAA TG-3Ј; neuropilin 2: 5Ј-AAG TGG GGG AAG GAG  ACT GT-3Ј and 5Ј-GTC CAC CTC CCA TCA GAG AA-3Ј . Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) cDNA fragment was amplified as a loading control using the following primers 5Ј-ACC ACA GTC CAT GCC ATC AC-3Ј and 5Ј-TCC ACC ACC CTG TTG CTG TA-3Ј. PCR products were separated on 1% agarose gels.
Cell proliferation assay
MGEC resuspended in MCDB 131 complete medium were plated on fibronectin coated (1 g/ml) 96-well microtiter plates (1.5ϫ10 4 cells/well) and allowed to attach at 37°C, 5% CO 2 for 4 h. After adherent cells were washed three times with PBS, they were incubated for 24 h in the presence of BrdU (1:10,000) in serum free MCDB medium with or without appropriate stimuli (sema 3C or VEGF 165 ) at 37°C, 5% CO 2 . MGEC proliferation was determined by measuring the amount of incorporated BrdU in the cells using a BrdU cell proliferation assay kit (Calbiochem, San Diego, CA).
Apoptosis assay
MGEC apoptosis was assessed using a FITC-conjugated marker (CaspACE FITC-VAD-FMK In Situ Marker; Promega) that binds to activated caspase 3, an in situ marker for apoptosis. Briefly, MGEC were plated on fibronectin coated (1 g/ml) chamber glass slides (3ϫ10 4 cells/chamber) and were grown in MCDB 131 complete medium for 24 h. At 40% confluency, cells were starved for 48 h in serum free MCDB medium either in the presence or in the absence of sema 3C (360 ng/ml) or for 24 h in the presence of cycloheximide (10 g/ml) at 37°C, 5% CO 2 . At the end of this time period, CaspACE FITC-VAD-FMK In Situ Marker (10 M) was added and cells were incubated for 20 min at 37°C protected from light. After being washed three times with PBS, cells were fixed in 10% buffered formalin for 30 min at room temperature, washed, and mounted with Fluromount G (Southern Biotech). Apoptotic cells were analyzed by fluorescence microscopy (Fluoview 300, Olympus). The percentages of apoptotic cells were calculated by counting at least 300 cells from two randomly selected fields for each condition in triplicate samples.
Cell adhesion assay
MGEC resuspended in serum free MCDB 131 medium with or without sema 3C or VEGF 165 were plated (1.0ϫ10 4 cells/ 0.1 ml/well) on 96-well tissue culture plates coated with either fibronectin or collagen I or gelatin (1 g/ml). Cells were then allowed to attach for 30 min at 37°C, 5% CO 2 . After being washed three times with PBS, adherent MGEC were fixed in 10% buffered formalin for 20 min at room temperature, washed, and stained with 0.1% crystal violet. The number of attached cells per well was counted under light microscopy. In some experiments, MGEC resuspended in serum free medium were incubated for 20 min at 37°C, 5% CO 2 in the presence or absence of anti-␣5␤1 (BMA5; Chemicon) and anti-␣V␤3 (LM609; Chemicon) function blocking antibodies (20 g/ml).
Cell migration assay
MGEC were seeded on the top of 8 m pore membrane of tissue culture inserts (Nunc; 3ϫ10 3 cells/insert) in MCDB 131 complete medium and allowed to adhere for 1 h, and the adherent cells were starved in serum free MCDB medium for 2 h. Then, the medium outside the insert was switched to serum free medium with or without sema 3C (500 ng/ml), and cells were incubated for 3 h at 37°C, 5% CO 2 . The inserts were washed, and cells were fixed in 10% buffered formalin for 20 min and stained with 0.1% crystal violet. MGEC from the topside of inserts were removed using cotton swabs, and the cells that had migrated to the bottom side of inserts were counted under light microscopy.
Capillary-like network formation
MGEC (2ϫ10 5 cells/gel) were plated on collagen I gels (1.2 mg/ml; Collaborative Research) with complete MCDB131 medium and allowed to attach for 3 h. Then, the medium was replaced with serum free medium ϩ10 M Cell-Tracker (Molecular Probes) ϩ recombinant sema 3C (360 ng/ml) or medium ϩ10 M Cell-Tracker ϩ vehicle (100 mM NaCl, 50 mM Tris-HCl, 192 mM glycine, 7 mM urea). Cells were imaged using phase and confocal microscopy (Olympus Fluoview FV300) at 12, 24, or 48 h.
Western blot analysis and immunoprecipitation
At 70% confluency, MGEC were starved for 12 h in serum free MCDB medium and then stimulated with sema 3C (360 ng/ml) and harvested at different time points using cell dissociation buffer (Life Technologies). Cells were lysed in modified radio-immunoprecipitation assay (RIPA) buffer (150 mM NaCl, 1.5 mM MgCl 2 , 5 mM NaP 2 O 7 , 20 mM HEPES, 1% Triton X-100, 10% glycerol, 5 mM EDTA, 50 mM NaF, and 2 mM Na 3 VO 4 ) with complete EDTA-free protease inhibitor (Roche Diagnostics, Indianapolis, IN). Protein concentration was determined using the bicinchoninic acid (BCA) assay (Sigma) following the manufacturer's instructions. 100 -150 g protein per sample were resolved in 7% SDS-PAGE, transferred to nitrocellulose membranes (BioRad, Hercules, CA), and blotted with anti-sema 3C (MAB#1728, R&D Systems), phosphospecific anti-␤ 1 integrin (pS 785; BioSource, Camarillo, CA), anti-focal adhesion kinase F-actin (FAK; #05-537, Upstate), and antiphosphorylated tyr 397 FAK (#44 -624G, Biosource) antibodies. HRP-conjugated secondary antibodies and the enhanced chemiluminescence (ECL) detection system (Amersham, Piscataway, NJ) were used to visualize protein signals. To demonstrate equal protein loading, blots were reprobed with antiactin antibody (Sigma). In additional experiments, MGEC resuspended in serum free medium were exposed to anti-␣ 5 ␤ 1 (BMA5; Chemicon) or anti-␣ V ␤ 3 (LM609; Chemicon) function blocking antibodies (20 g/ml), anti-VEGF neutralizing Ab (1 g/ml; #AF393, R&D Systems), anti-mouse VEGFR2 neutralizing Ab (1 g/ml; MAB#4431, R&D Systems), anti-NP-1 neutralizing Ab (5 g/ml; AF#566, R&D Systems), or anti-NP2 neutralizing Ab (5 g/ml; AF#567, R&D Systems) for 45 min at 37°C, 5% CO 2 prior to stimulation with sema 3C (360 ng/ml) for various periods of time (10 min to 24 h). To assess sema 3C and VEGF-A secretion, cell supernatants were collected at the end of the experiments, concentrated (ϫ20 -240) using Amicon Ultra filters (Millipore), and 20 -50 l samples were resolved by SDS-PAGE and immunoblotted with anti-sema 3C (MAB#1728, R&D Systems) or anti-VEGF (sc#507, Santa Cruz Biotechnology, Santa Cruz, CA) antibodies as described above. For Immunoprecipitation, the concentrated supernatant (240ϫ) was incubated with 5 g/ml of antisema 3C monoclonal antibody for 4 h at 4°C, and then 50 l of protein G-agarose (#1719416, Roche) were added and incubated overnight at 4°C in a tube rotator. Beads with the antigen-antibody complex were pelleted by centrifugation and washed three times with PBS. To release antigen-antibody complex, beads were resuspended in 2 ϫ protein sample buffer and boiled 5 min at 100°C. Immunoprecipitates were resolved by SDS-PAGE and analyzed by Western blot.
RESULTS
We determined that our previously characterized mouse glomerular endothelial cells (26) express sema 3C mRNA and its signaling receptors, plexins A1, A2, and D1 mRNAs (Fig. 1A) , suggesting that sema 3C may have autocrine functions. We observed that sema 3C receptors' mRNA expression is not regulated by ligand availability (Fig. 1A) . Sema 3C protein was detected in MGEC cell lysates and in their supernatant by Western blotting and immunoprecipitation, respectively. These data indicate that sema 3C is expressed and secreted by glomerular endothelial cells (Fig. 1B) . We documented the specificity of the sema 3C antibody by immunoblotting that detected recombinant sema 3C as a single band of the expected M r (Ϸ83 kDa) and no crossreactivity with recombinant sema 3A and sema 3F (Fig.  1C) . We previously showed that MGEC also express the binding coreceptors neuropilin 1 and neuropilin 2 (29) .
Cell adhesion assays were performed to determine the role of sema 3C. Sema 3C significantly increased glomerular endothelial cell adhesion to fibronectin and collagen I substrates, whereas it did not alter adhesion to gelatin, suggesting that integrins could mediate this effect. Sema 3C-induced adhesion was similar to that induced by VEGF 165 ( Fig. 2A-C) . Sema 3C dose-response experiments revealed maximal cell adhesion at 360 ng/ml (Fig. 2D) . To test whether integrins play a role in sema 3C-induced increased adhesion, cell adhesion experiments were performed in the presence or absence of ␤ 1 and ␤ 3 integrin function blocking antibodies (BMA5 and LM609, respectively). We observed that ␤ 1 and ␤ 3 integrin blocking antibodies prevented sema 3C-induced adhesion, Figure 1 . MGEC express sema 3C and its receptors: plexins and neuropilins. A) RT-PCR analysis of RNA isolated from untreated (control) or sema 3C-treated MGEC. cDNAs were amplified using specific primers for sema 3C, plexins, neuropilins, or GAPDH. 25 PCR cycles were used for sema 3C and NP1, and 30 cycles were used for NP2 and plexins. Amplified products were separated on TAE/agarose gels. B) Western blots (WB) showing sema 3C protein in MGEC lysates and supernatant; detection of secreted sema 3C required immunoprecipitation before immunoblotting (IP:WB). C) Western blot showing sema 3C Ab specificity: 800 ng of recombinant sema 3A, sema 3C, and sema 3F were resolved in 8% SDS gel and immunoblotted. M r (kDa) is shown on right-hand side of immunoblots.
indicating that integrins mediate this effect (Fig. 2E) . We determined that sema 3C induces a significant increase in ␤ 1 integrin serine phosphorylation, as indicated by Western analysis with a phosphoserine-specific pS 785 ␤ 1 integrin antibody (Fig. 2F) . Sema 3C-induced ␤ 1 integrin serine phosphorylation was not altered by prior exposure to anti-VEGFR2 neutralizing antibodies but was abolished by anti-NP1 and anti-NP2 neutralizing Ab (Fig. 2G) , suggesting that sema 3C effects on ␤ 1 integrin phosphorylation are independent of VEGF-A and are likely mediated by NP/plexin signaling. We examined whether sema 3C signaling induced focaladhesion kinase (FAK) tyrosine phosphorylation and found that neither FAK expression level nor its Tyr 397 phosphorylation were altered by sema 3C (Fig. 2H) .
Next, we examined the effect of the sema 3C on endothelial cell proliferation and survival. Sema 3C induced glomerular endothelial cell proliferation in a dose-response manner (Fig. 3A) . Sema 3C-induced increase in endothelial cell proliferation was similar to that induced by VEGF-A (Fig. 3B) . Sema 3C reduced starvation-induced apoptosis by 46 Ϯ 3% compared with control, as indicated by an in situ marker of activated caspase 3 (Fig. 4 A-D) .
We next assessed sema 3C effect on directional endothelial cell migration and tube formation. Sema 3C increased migration of endothelial cells by 44 Ϯ 11% at 3 h, as compared with control (Fig. 5A) . Sema 3C significantly stimulated endothelial cell network and tube formation at 48 h (Fig. 5B,C) . Since sema 3C functions described herein are similar to VEGF-A functions, we asked whether sema 3C regulates VEGF-A expression and secretion by endothelial cells. We determined that sema 3C induced a Ͼ13-fold increase in VEGF 120 secretion to the MGEC supernatant, whereas VEGF 164 expression in MGEC lysates remained unchanged (Fig. 5D) . VEGF 120 secretion was maximal after 30 min exposure to sema 3C, suggesting that it does not require protein synthesis (Fig. 5E) . Sema 3C-induced VEGF 120 secretion was not prevented by ␤ 1 or ␤ 3 integrin function blocking antibodies (Fig. 5F ), indicating that integrins do not mediate VEGF 120 secretion. Sema 3C-induced VEGF 120 secretion was decreased by NP-1 and NP-2 neutralizing antibodies ( Fig.  5G ) and was not altered by VEGFR2 neutralizing Ab Figure 2 . Sema 3C stimulates MGEC adhesion and induces ␤ 1 integrin phosphorylation. Adhesion of MGEC to fibronectin (A), collagen (B), and gelatin (C), at each substrate concentration of 1 g/ml, was assessed in the absence (control) or in the presence of sema 3C (180 ng/ml) or VEGF (30 ng/ml). D) Dose response to sema 3C (180 -480 ng/ml) showing that sema 3C regulates MGEC adhesion to fibronectin, *P Ͻ 0.05 control vs. sema 3C, **P Ͻ 0.05 sema 3C 480 vs. 180 ng/ml; E) MGEC adhesion to fibronectin (1 g/ml) in the absence (controlϭgray bars) or in the presence of sema 3C (360 ng/ml; red bars) with or without antibodies blocking (data not shown), suggesting that sema 3C regulates VEGF 120 secretion via NP/ plexin signaling.
Taken together, the data indicate that sema 3C stimulates glomerular endothelial cell survival and proliferation and promotes its adhesion, migration, and vascular morphogenesis in vitro by inducing ␤ 1 integrin phosphorylation and VEGF 120 secretion via NP/plexin signaling.
DISCUSSION
In this study, we present evidence indicating that sema 3C is produced and secreted by glomerular endothelial cells and that sema 3C promotes endothelial cell survival and proliferation and stimulates cell adhesion, migration, and tube formation in vitro by inducing ␤ 1 integrin serine phosphorylation and VEGF 120 secretion via NP/plexin signaling.
Class 3 semaphorins modulate cell migration and provide site-specific guidance cues to neurons, neural crest, and endothelial cells by modulating integrin function and cytoskeletal dynamics (2, 12) . The specificity of sema 3 signals results from the plexin-neuropilin present in the receptor complex (12) . Sema 3C binds to plexin A2 /NP-1 and to plexin A2/NP-2 complexes (13). In addition, sema 3C binding increases significantly when NP-1 or NP-2 dimerize with plexin D1 (5) .
Expression studies reported sema 3C transcripts in the conotruncal area of the developing heart and in the aorta and pulmonary vessels, suggesting that sema 3C may provide attractive signals to migrating neural crest and endothelial cells (22) . Ablation of the sema 3C gene resulted in troncus arteriosus and interruption of the aortic arch and demonstrated that sema 3C chemoattractive cues are required for normal outflow tract development (25) . Disruption of plexin D1 revealed a similar phenotype, indicating that plexin D1 functions as an endothelial cell specific sema 3C receptor in vivo (5, 7). During nervous system development, sema 3C provides chemoattractive guidance cues to GABAergic migrating axons toward hippocampal interneurons and induces growth cone collapse of sympathetic neurons (8, 10) . Sema 3C induces survival and neurite outgrowth of rat cerebellar granule neurons in culture (9) . Sema 3C was found to be up-regulated in tumor cell lines with invasive and metastatic behavior (30 -32) and in sinovial fluid from rheumatoid arthritis patients (33) . Taken together, these studies suggest that sema 3C function promotes cell survival and provides chemoattractive cues in multiple cell types and chemorepulsive cues to some neurons. To our knowledge, the role of sema 3C signaling in endothelial cell function has not been examined previously.
The studies reported here revealed that sema 3C and its signaling receptors, plexins A1, A2, and D1 mRNAs, are expressed in mouse glomerular endothelial cells, suggesting a possible autocrine system. We had previously reported expression of the binding receptors, neuropilin 1 and 2, in these endothelial cells (29) . Previous reports did not detect sema 3C mRNA in human vein and rat aortic endothelial cells (20, 34) . The discrepancy may be due to a species or vessel size Figure 3 . Sema 3C induces MGEC proliferation. Subconfluent cultures of MGEC on fibronectin were incubated in serum free medium with or without sema 3C or VEGF-A in the presence of BrdU for 24 h. A) Dose-response curve to sema 3C (180 -480 ng/ml); B) Sema 3C (360 ng/ml) and VEGF (30 ng/ml) stimulate MGEC proliferation similarly. Data are expressed as mean Ϯ sd optical density (OD) at 450/550 nm (A), and mean Ϯ sd percent changes above control BrdU incorporation (B), n ϭ 3 independent experiments, quadruplicates were carried out for each condition, *P Ͻ 0.05 compared with control. Figure 4 . Sema 3C reduces MGEC apoptosis. Subconfluent cultures of MGEC on fibronectin were incubated in serum free medium in the absence (control) or in the presence of sema 3C (360 ng/ml) for 48 h or cycloheximide (10 g/ml) for 24 h; Apoptotic cells were detected by fluorescence microscopy using a FITC-conjugated in situ marker for activated caspase 3. Bar graph is mean Ϯ se percent change in the number of apoptotic cells/field sema 3C vs. control; n ϭ 3 independent experiments. difference in the origin of the endothelial cells (35) . We determined that mouse glomerular endothelial cells express and secrete sema 3C protein. Sema 3C is readily detected by immunoblotting in endothelial cell lysates. Conversely, sema 3C secretion in serum free, control conditions is low, requiring immunoprecipitation to be detected. The regulation of sema 3C expression and secretion remains unknown. Our data clearly indicate that sema 3C signals and has several functions in mouse glomerular endothelial cells: 1) stimulates proliferation and decreases apoptosis, and 2) enhances endothelial cell adhesion, migration, and capillary-like tube formation. We showed that sema 3C-induced increase in endothelial cell adhesion is prevented by ␤ 1 and ␤ 3 integrin function blocking antibodies and that there is a concomitant increase in ␤ 1 integrin phosphorylation on Ser-785 within the time frame of the cell adhesion assay, suggesting that sema 3C function in vitro is mediated by integrins and, at least in part, by ␤ 1 integrin serine 785 phosphorylation. These findings are consistent with previous studies indicating that changes in the Ser-785 phosphorylation state modulate ␤ 1 integrin function promoting cell adhesion (36, 37) . Sema 3C effects on ␤ 1 integrin appear to be independent of VEGF-A and mediated by NP/plexin signaling, as indicated by VEGFR2 and NP1 or NP2 neutralizing Ab experiments, respectively (see Fig. 2G ).
Sema 3C functions in endothelial cells are remarkably similar to well-established VEGF-A functions, e.g., positive regulator of cell proliferation and survival, migration, and tube assembly (38) . Thus, we explored a possible crosstalk between sema 3C and VEGF-A pathways. Data revealed that sema 3C strongly induces VEGF 120 secretion by endothelial cells, documenting for the first time a mechanism linking sema 3C and VEGF-A signaling pathways. Time-course experiments showed a maximal stimulation within 30 min of sema 3C exposure and a lack of further VEGF 120 accumulation, suggesting that protein synthesis is not required for VEGF 120 secretion. VEGF 120 secretion is not mediated by ␤ 1 or ␤ 3 integrins, as described in cancer cells (39) and appears to be mediated by a sema 3C-NP/ plexin signaling mechanism because it is blocked by anti-NP-1 and anti-NP2 but not by anti-VEGFR2 neutralizing antibodies. VEGF 120 does not compete with sema 3C for NP-1 receptor binding (40) . VEGF 120 is freely diffusible and does not bind heparin or heparan sulfate proteoglycans; therefore, it does not generate concentration gradients (41) . Accordingly, it is unlikely that VEGF 120 secretion may be responsible for sema 3C-induced cell migration. It is unclear whether sema 3C-induced secreted VEGF 120 contributes to enhanced endothelial cell adhesion, but it likely promotes endothelial cell proliferation and survival, as previously reported (41) (42) (43) , and thereby may contribute to enhance sema 3C-induced capillary-like tube formation. Sema 3C does not alter the expression of VEGF 164 , the major VEGF-A isoform, nor does it induce its secretion. The tissue-specific regulation of VEGF-A isoforms is poorly understood, and VEGF-A secretion has been mostly assessed using ELISA assays that do not discriminate between VEGF 120 and VEGF 164 (42, 43) . Thrombin was shown to induce VEGF 120 secretion by megakaryocytes and platelets within the same time Figure 5 . Sema 3C induces MGEC directional migration, capillary-like network formation and VEGF-A secretion. A) Sema 3C (500 ng/ml) induced a 44 Ϯ 11% increase in MGEC migration at 3 h. Data are mean Ϯ se cell counts from three independent experiments performed in duplicate. *P Ͻ 0.05 sema 3C vs. control; B) MEGC plated on collagen I gels in serum free medium for 48 h showing minimal network formation; C) MEGC plated on collagen I gels and exposed to sema 3C (360 ng/ml) for 48 h developed extensive capillary-like network. Images are representative of 3 independent experiments performed in triplicate. D) Western blot showing VEGF 164 expression in control and sema 3C-treated MGEC cell lysates and VEGF 120 secretion to the supernatant, demonstrating that sema 3C induces significant VEGF 120 secretion. E) Time course of sema 3C-induced VEGF 120 secretion. F) Western blot showing that VEGF 120 secretion is not mediated by frame observed in our studies in endothelial cells (44) . Although the physiological role of sema 3C in modulating VEGF 120 isoform needs to be further explored, the findings reported here suggest autocrine cooperation between sema 3C and VEGF-A that promotes endothelial cell homeostasis.
Sema 3C functions in endothelial cells described herein are opposite to those reported for sema 3A (6, 20) . In addition, our data indicate that sema 3C signals differently from sema 3A. First, sema 3C enhanced ␤ 1 integrin function by inducing its phosphorylation, whereas sema 3A inhibits integrin activity (20) . Second, sema 3C did not alter focal adhesion kinase activity (FAK), whereas sema 3A decreased FAK phosphorylation and up-regulated FRNK (Villegas, G., J. Rovin, J. Teichman, J. T. Parsons, and A. Tufro, unpublished observations). Third, sema 3C reduced endothelial cell apoptosis, whereas sema 3A impairs survival pathways and induces apoptosis (this study, refs. 6, 27). Fourth, sema 3C and VEGF 165 have similar functions (this study), whereas sema 3A and VEGF 165 compete for NP-1 binding and have opposite effects on integrin activity (6, 20, 40, 45) . Lastly, sema 3C induced VEGF 120 secretion, whereas sema 3A did not (this study and data not shown).
In summary, we conclude that sema 3C is a positive regulator of endothelial cell function that mediates endothelial cell survival, proliferation, adhesion, migration, and tube formation in vitro by stimulating integrins and VEGF 120 secretion. Sema 3C functions are similar to VEGF-A and opposite to sema 3A, suggesting that the combinatorial sum of these proteins' gradients may be important for endothelial cell migration, morphogenesis, and remodeling in specific vascular beds.
whereas it did not alter adhesion to gelatin, suggesting that integrins may mediate this function (Fig. 1A-C) . These changes were similar to those induced by VEGF 165 (Fig. 1A, B) . A sema 3C dose response was observed with maximal cell adhesion at 360 ng/ml (Fig.  1D) . To test whether integrins play a role in sema 3C-induced increased adhesion, cell adhesion experiments were performed in the presence or absence of integrin function blocking antibodies (BMA5 and LM609, Chemicon). As shown in Fig. 1E , anti-␣ 5 ␤ 1 and anti-␣ V ␤ 3 integrin blocking antibodies prevented sema 3C-induced adhesion, indicating that integrins mediate this effect. Sema 3C induced a significant increase in ␤ 1 integrin serine phosphorylation (Fig. 1F) , as indicated by Western analysis with a phospho-serine specific pS 785 ␤ 1 integrin antibody. Sema 3C-induced ␤ 1 integrin serine phosphorylation was not altered by prior exposure to anti-VEGFR2 neutralizing Ab but was abolished by anti-NP1 and anti-NP2 neutralizing antibodies (Fig.  1G) , suggesting that sema 3C effects on ␤ 1 integrin phosphorylation are independent of VEGF-A and are likely mediated by NP/plexin signaling. We examined whether sema 3C signaling induced focal adhesion kinase (FAK) tyrosine phosphorylation and found that neither FAK expression level nor its tyrosine 397 phosphorylation was altered by sema 3C (Fig. 1H) .
We next assessed sema 3C effect on directional endothelial cell migration and tube formation. Sema 3C increased migration of endothelial cells by 44 Ϯ 11% at 3 h, as compared with control ( Fig. 2A) . Sema 3C significantly stimulated endothelial cell network and tube formation at 48 h (Fig. 2B, C) .
Sema 3C induces VEGF-A secretion by endothelial cells
Sema 3C functions in endothelial cells reported here are remarkably similar to well-established VEGF-A functions, e.g., positive regulator of cell proliferation and survival, migration, and tube assembly. Thus, we asked whether sema 3C regulates VEGF-A expression and secretion by endothelial cells. We determined that sema 3C induced a Ͼ13-fold increase in VEGF 120 secretion to the MGEC supernatant, whereas VEGF 164 expression in MGEC lysates remained unchanged (Fig.  2D) . The time course of VEGF 120 secretion suggests it Figure 1 . Sema 3C stimulates MGEC adhesion and induces ␤ 1 integrin phosphorylation. Adhesion of MGEC to fibronectin (A), collagen (B), and gelatin (C), at each substrate concentration of 1 g/ml, were assessed in the absence (control) or in the presence of sema 3C (180 ng/ml) or VEGF (30 ng/ml). D) Dose response to sema 3C (180 to 480 ng/ml) showing that sema 3C regulates MGEC adhesion to fibronectin, *P Ͻ 0.05 control vs. sema 3C, **P Ͻ 0.05 sema 3C 480 vs. 180 ng/ml; E) MGEC adhesion to fibronectin (1 g/ml) in the absence (controlϭgray bars) or in the presence of sema 3C (360 ng/ml; red bars) with or without antibodies blocking does not require protein synthesis (Fig. 2E) . Sema 3C-induced VEGF 120 secretion was not prevented by ␤1 or ␤3 integrin function blocking antibodies (Fig. 2F) , suggesting that integrins do not mediate VEGF 120 secretion. Sema 3C-induced VEGF 120 secretion was not prevented by blockade of VEGFR2 signaling but was decreased by NP1 and NP2 neutralizing antibodies (Fig. 2G) , suggesting that sema 3C regulates VEGF 120 secretion via NP/ plexin signaling. These data document for the first time a crosstalk between sema 3C and VEGF-A signaling pathways (see Fig. 3 ).
CONCLUSIONS AND SIGNIFICANCE
To our knowledge, the specific functions of sema 3C in endothelial cells have not been examined previously. Here we report that 1) sema 3C is naturally expressed and secreted by endothelial cells, and 2) sema 3C stimulates glomerular endothelial cell survival and proliferation and promotes their adhesion, migration, and tube formation in vitro by inducing ␤ 1 integrin phosphorylation and VEGF 120 secretion. Mechanistically, we determined that sema 3C signaling stimulates integrin function via NP/plexin and induces VEGF-A secretion in a NP/plexin-dependent, integrin-independent manner, potentially generating a positive feedback loop to activate integrins and promote endothelial cell survival, migration, and tube formation (Fig. 3) . Our findings imply a new paradigm involving sema 3C and VEGF-A similar functions and antagonistic functions between sema 3C and sema 3A in endothelial cells. The physiological consequences of the crosstalk between VEGF-A and sema 3C signaling are being actively examined. (1) . Sema 3C binds to its neuropilin-plexin receptor complex and induces integrin activation, specifically ␤ 1 integrin Ser-785 phosphorylation (2) , and increases VEGF 120 secretion to the media by NP2-dependent and VEGFR2-and integrin-independent mechanism (3). Solid arrow indicates a proven mechanism and dashed arrow, a possible mechanism. Sema 3C signaling stimulates endothelial cell (EC) adhesion, migration, and capillary-like tube formation and promotes EC proliferation and survival.
